The Orthopaedics segment at Smith & Nephew focuses on developing and marketing a comprehensive range of joint reconstruction and trauma management solutions. This includes knee and hip implants designed for primary and revision procedures, as well as trauma and extremities products used in the stabilization of severe fractures and deformity correction. Research and development efforts are directed towards enhancing implant longevity, improving surgical techniques, and incorporating advanced materials and coatings to promote bone integration and reduce the risk of infection. The segment leverages technologies such as robotic-assisted surgery and patient-specific implants to improve surgical precision and patient outcomes. Smith & Nephew's orthopaedic solutions aim to restore mobility, alleviate pain, and enhance the quality of life for patients with musculoskeletal conditions, positioning the company as a key player in the global orthopaedics market.

Smith & Nephew's Sports Medicine segment is dedicated to providing surgeons with advanced tools and techniques for minimally invasive joint repair. This includes a wide array of instruments, technologies, and implants necessary for arthroscopic procedures targeting soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. The segment's R&D activities focus on developing innovative fixation devices, bioabsorbable materials, and regenerative technologies to enhance tissue healing and restore joint function. Arthroscopic enabling technologies, such as fluid management equipment, high-definition cameras, and radiofrequency devices, are also a key component of this segment, assisting with visualization and tissue resection during surgery. Smith & Nephew's sports medicine solutions aim to reduce patient recovery times, minimize post-operative complications, and enable athletes and active individuals to return to their desired activities, solidifying the company's position as a leader in the sports medicine market.

The Advanced Wound Management segment at Smith & Nephew offers a broad portfolio of products for the treatment and prevention of acute and chronic wounds, including leg, diabetic, and pressure ulcers, burns, and post-operative wounds. This segment's research and development efforts are focused on advanced wound bioactives, such as biologics and bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products like skin, bone graft, and articular cartilage substitutes. Advanced wound devices, including traditional and single-use negative pressure wound therapy and hydrosurgery systems, are also a key focus. Smith & Nephew's wound management solutions aim to promote faster healing, reduce infection rates, and improve patient outcomes, addressing the significant burden of chronic wounds on healthcare systems worldwide. The company's innovative technologies and comprehensive product range position it as a leading provider in the advanced wound care market.